Otsuka Pharma's antipsychotic agent Abilify gets Japanese nod for new ... - pharmabiz.com
Otsuka Pharma's antipsychotic agent Abilify gets Japanese nod for new .
Understanding autism - Philippine Star
Understanding autismPhilippine StarBased on clinical trial data, there is positive evidence for using risperidone (Risperdal) and aripiprazole (Abilify) for improving behaviors such as aggression, irritability, and repetitive behaviors.
New products provide solid quarter for B-MS - Pharma Times
New products provide solid quarter for B-MSPharma TimesThe company's bloodthinner blockbuster Plavix (clopidogrel) slipped 3% to $1.
OTSUKA HOLDINGS CO LTD : Otsuka announces 2011 fourth quarter U.S. net sales ... - 4-traders (press release)
OTSUKA HOLDINGS CO LTD : Otsuka announces 2011 fourth quarter U.
The risks of prescribing antipsychotics to kids - Globe and Mail
Globe and MailThe risks of prescribing antipsychotics to kidsGlobe and Mail(Of the seven atypical antipsychotics on the market in Canada, only one, aripiprazole, sold under the brand Abilify, is approved for use in young people.